Clinical Trial Update: A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for the radiopharmaceutical 177Lu-IM-3050 evaluating safety and dosing in participants with solid tumors; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 177Lu-IM-3050

Snippet

Sponsor: Immunome, Inc. | Conditions: Solid Malignancies | EARLY_Phase 1 | Status: RECRUITING